ArticleCureus2026
Fatal Hyperphosphatemia After a Single Phosphate Enema in Ogilvie Syndrome.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Phosphate-containing enemas are commonly used for constipation and fecal impaction but may cause severe electrolyte disturbances when retained, particularly in patients with impaired intestinal motility. We report a fatal case of extreme hyperphosphatemia after a single phosphate enema in a 75-year-old woman with acute colonic pseudo-obstruction (Ogilvie syndrome). Despite normal baseline renal function, the patient rapidly developed profound metabolic derangements, including marked hyperphosphatemia, severe hypocalcemia, hypernatremia, hyperkalemia, and metabolic acidosis, leading to distributive shock and multiorgan failure. This case highlights the heightened risk of phosphate absorption in pseudo-obstruction, where colonic dilation and potential mucosal ischemia may markedly increase epithelial permeability. Clinicians should avoid phosphate-containing enemas in elderly or high-risk patients with impaired intestinal motility and prioritize safer decompression strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.